One-month post-surgery, the expression rates of TSGF, CEA, and AFP drastically declined, thus suggesting the possibility of using TSGF as a biomarker to evaluate the effect of the radical operation on colon cancer. The gene discussed is CEACAM5; the disease is malignant colon neoplasm.